News

Golimumab, Centocor’s and Schering-Plough’s next-generation human anti-TNF-alpha monoclonal antibody, is being studied as an every four week subcutaneous injection and an intravenous (IV) infusion therapy. Pending regulatory approval

The Phase I study will evaluate the safety, tolerability and pharmacokinetic profile of AEG33773 using a randomized, double blind, placebo controlled, single ascending dose design in healthy male

The system is based on a miniature 3.4 mm distal stereoscopic 3D camera targeting Minimal Invasive laparoscopic and endoscopic Surgery. Visionsense’s stereoscopic 3D camera enables and enhances MIS

This Phase IIA study is designed to evaluate the safety and efficacy of Oramed’s oral insulin capsule on Type II diabetic volunteers. This study is slated to begin

Under the terms of the agreement, Corgenix has the exclusive rights outside of Japan to further develop the serum amyloid technology, including adapting to research and clinical diagnostic

The European Group for the Study of Insulin Resistance (EGIR) has compiled large numbers of biological samples from studies conducted at 19 clinical research centers across Europe as

The claims of the newly issued patent cover a broad range of methods for the use of a specific sequence of small interfering RNAs (siRNA), including bevasiranib, to

The two vitrification products that Vitrolife has obtained approval for are RapidVit Cleave and RapidWarm Cleave. Products for vitrification involve considerable technological progress and open up new opportunities

The Coolrail linear ablation pen is designed to facilitate the creation of an expanded cardiac ablation lesion set during a minimally invasive off-pump procedure. Additionally, the first patient